首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   89篇
  免费   5篇
  国内免费   2篇
儿科学   3篇
妇产科学   1篇
基础医学   14篇
口腔科学   1篇
临床医学   10篇
内科学   11篇
皮肤病学   2篇
神经病学   1篇
特种医学   1篇
外科学   12篇
综合类   5篇
预防医学   6篇
眼科学   9篇
药学   15篇
肿瘤学   5篇
  2023年   2篇
  2022年   3篇
  2021年   1篇
  2020年   4篇
  2019年   5篇
  2018年   1篇
  2017年   2篇
  2015年   3篇
  2014年   9篇
  2013年   5篇
  2012年   5篇
  2011年   6篇
  2010年   7篇
  2009年   3篇
  2008年   5篇
  2007年   6篇
  2006年   3篇
  2005年   6篇
  2004年   3篇
  2003年   2篇
  2002年   8篇
  2001年   2篇
  2000年   2篇
  1999年   2篇
  1987年   1篇
排序方式: 共有96条查询结果,搜索用时 15 毫秒
1.
Inflammation Research - Non-alcoholic fatty liver disease (NAFLD) is a multifaceted disease allied with various metabolic disorders, obesity and dysbiosis. Gut microbiota plays an influential role...  相似文献   
2.
Contrast‐enhanced spectral mammography (CESM) has a number of uses including the work‐up of inconclusive findings on mammography, assessment of breast symptoms, cancer staging, evaluation of response to neoadjuvant chemotherapy and recently as an alternative to magnetic resonance imaging (MRI) in high‐risk screening. CESM can be swiftly incorporated into the workflow of busy breast clinics. We share our experiences with CESM at a large breast assessment centre in Western Australia.  相似文献   
3.
4.
5.
6.
A decision support tool has been developed as part of a suite of on‐line evidence‐based and consensus‐based guidelines Diagnostic imaging Pathways (DIP): www.imagingpathways.health.wa.gov.au ) in the form of an algorithmic flow chart with supporting evidence and consensus to inform referrers to diagnostic imaging and radiologists as to the optimum strategy for surveillance and diagnosis of primary hepatocellular cancer (HCC) in those patients with risk factors of this disease. A literature review, including reference to several international consensus‐based expert guidelines, has been employed to develop this tool.  相似文献   
7.
8.
9.
10.
The present research was aimed at the enhancement of the dissolution rate of atorvastatin calcium by the solid dispersion technique using modified locust bean gum. Solid dispersions (SD) using modified locust bean gum were prepared by the modified solvent evaporation method. Other mixtures were also prepared by physical mixing, co-grinding, and the kneading method. The locust bean gum was subjected to heat for modification. The prepared solid dispersions and other mixtures were evaluated for equilibrium solubility studies, content uniformity, FTIR, DSC, XRD, in vitro drug release, and in vivo pharmacodynamic studies. The equilibrium solubility was enhanced in the solid dispersions (in a drug:polymer ratio of 1:6) and other mixtures such as the co-grinding mixture (CGM) and kneading mixture (KM). Maximum dissolution rate was observed in the solid dispersion batch SD3 (i.e. 50% within 15 min) with maximum drug release after 2 h (80%) out of all solid dispersions. The co-grinding mixture also exhibited a significant enhancement in the dissolution rate among the other mixtures. FTIR studies revealed the absence of drug-polymer interaction in the solid dispersions. Minor shifts in the endothermic peaks of the DSC thermograms of SD3 and CGM indicated slight changes in drug crystallinity. XRD studies further confirmed the results of DSC and FTIR. Topological changes were observed in SEM images of SD3 and CGM. In vivo pharmacodynamic studies indicated an improved efficacy of the optimized batch SD3 as compared to the pure drug at a dose of 3 mg/kg/day. Modified locust bean gum can be a promising carrier for solubility enhancement of poorly water-soluble drugs. The lower viscosity and wetting ability of MLBG, reduction in particle size, and decreased crystallinity of the drug are responsible for the dissolution enhancement of atorvastatin. The co-grinding mixture can be a good alternative to solid dispersions prepared by modified solvent evaporation due to its ease of preparation and significant improvement in dissolution characteristics.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号